The largest database of trusted experimental protocols

Qiaamp rna kit

Manufactured by Qiagen
Sourced in Germany, United States

The QIAamp RNA kit is a laboratory product designed for the purification of total RNA from various sample types. It utilizes a spin-column-based technology to efficiently capture and purify RNA, which can then be used for downstream applications such as reverse transcription and PCR analysis.

Automatically generated - may contain errors

12 protocols using qiaamp rna kit

1

Quantitative Analysis of EYA4 and Zeocin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from transfected COS7 cells using QIAamp® RNA kit following the manufacturer’s instructions (QIAGEN). Reverse transcription was carried out using 1μg of RNA and random hexamers with the Transcriptor First Strand cDNA Synthesis Kit (Roche). EYA4 and Zeocin cDNAs were amplified using the primers EYA4F 5′-CGAGGAAGAGGCCGGAAA-3′ and EYA4R 5′-CAGCTTCCTCATCCAGTCCAC-3′ and ZeoF 5′-GGCTGCTCGCCGATCTCG-3′ and ZeoR 5-′GACCGGCTCGGGTTCTCC-3′ respectively and the 390 and 230 pb generated products were separated in a 2% agarose gel.
+ Open protocol
+ Expand
2

Total RNA Extraction and Protein Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from either cell lines or xenograft tissues using a QIAamp RNA kit (Qiagen). Cells were lysed with M-PER Mammalian Protein Extraction Reagent (Thermo scientific) containing protease inhibitor cocktail (Roche Life Science). Protein quantification was determined with BCA protein assay kit (Thermo scientific).
+ Open protocol
+ Expand
3

EXOSC8 Splicing Variant Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To study the effect of the missense variant c.238 G > A (p.Val80Ile) on splicing, total RNA was isolated from patient’s cultured primary fibroblasts using QIAamp RNA kit (Qiagen, Hilden, Germany). Five µg of total RNA were reverse transcribed into cDNA using COSMO cDNA Synthesis Kit (Willowfort, Birmingham, United Kingdom). The synthesized cDNA was then used as a template for partial amplification of the EXOSC8 gene (from exons 3 to 7) using one pair of primers: 5′-CCACAACTGTCAACATCGGT-3′ and 5′-CAGACAAGCTTTCCTGGAGA-3′ under the following conditions: 96 °C for 2 min, a total of 35 cycles of 94 °C for 30 s, annealing at 62.5 °C for 30 s, 72 °C for 30 s, and a final extension of 72 °C for 5 min. PCR products were separated by 1% agarose gel electrophoresis and then purified and sequenced as described above.
+ Open protocol
+ Expand
4

DBS Nucleic Acid Isolation with QIAamp

Check if the same lab product or an alternative is used in the 5 most similar protocols
We described details of the laboratory procedures in our previous work published elsewhere [7 (link)]. We performed nucleic acid isolation from DBS using the QIAamp RNA kit (Qiagen GmbH, Germany), according to manufactures instructions. Briefly, we excised DBS samples by hand using scissors and placed two of the spots in lysis buffer and incubated at room temperature with gentle rotation for 30 min, subsequent washes and a final elution of 50μl.
+ Open protocol
+ Expand
5

Detecting ABL1 Kinase Mutations in Leukemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the detection of mutations in the ABL1 kinase domain, RNA was extracted from SupB15-WT, and SupB15-RT cells using QIAamp RNA Kit (Qiagen, Düsseldorf, Germany) and cDNA was synthesized using SuperScript IV VILO (Invitrogen, Karlsruhe, Germany) kit as mentioned earlier. For exclusive BCR-ABL1 kinase domain amplification the primers listed in Table S1c were used (37 (link),38 (link)).
PCR products were sequenced by Seqlab (Göttingen, Germany) using the AN4 (Table S1c) (38 (link),39 (link)). The sequence data were analyzed for mutations with Clone Manager Professional (Sci ED Software, Morrison, NC, USA).
+ Open protocol
+ Expand
6

RNA Extraction and cDNA Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated using QIAamp RNA Kit (QIAGEN catalog #52304) for blood samples or TRIzol reagent (Invitrogen™ catalog #15596-026) for solid samples. The quality of total RNA was assessed using a Bioanalyzer 2100 (Agilent Technologies, USA). The first-strand cDNA was synthesized with SMARTer PCR cDNA Synthesis Kit (Clontech catalog #634925) and the 3′ SMART CDS Primer IIA (5′-AAGCAGTGGTATCAACGCAGAGTACT(30)N−1N-3′), according to the manufacturer’s protocol. The second-strand cDNA was synthesized and the product was further amplified with PrimeSTAR HS DNA Polymerase (TAKARA catalog #R010A) and Primer M1 (5′-AAGCAGTGGTATCAACGCAGAGT-3′) for 12–15 PCR cycles (15 s at 95 °C, 30 s at 65 °C, and 6 min at 68 °C). cDNA product was purified with TaKaRa MiniBEST DNA Fragment Purification Kit (Catalog #9761) and dissolved with sterile RNAse-free water to a final concentration of 100 ng/μl.
+ Open protocol
+ Expand
7

Orthohantavirus RNA Extraction and RT-PCR Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Orthohantavirus nucleic acids were extracted from host animal liver and lung tissues as well as from patient blood samples using the QIAamp RNA kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The viral RNA is stored in a −80 °C freezer until use. RT-PCR amplification of the L-gene fragment of orthohantavirus was performed on the extracted RNA with the orthohantavirus universal primer: HAN-L-F1: 5′-ATGTAYGTBAGTGCWGATGC-3′, HAN-L-R1: 5′-AACCADTCWGTYCCRTCAT-C-3′; HAN-L-F2: 5′-TGCWGATGCHACIAARTGGTC-3′, and HAN-L-R2: 5′-GCRTCRTCWGARTGRTGDGCAA-3′ [24 (link)], using the FastKing One-Step RT-PCR Kit (TIANGEN BIOTECH, Beijing, China) and Premix Ex Taq polymerase (TaKaRa Bio Inc, Shiga, Japan) according to the manufacturer’s instructions. Nested RT-PCR was performed with a total reaction system of 25 μL. Reaction conditions: reverse transcription at 42 °C for 30 min, pre-denaturation at 95 °C for 3 min, followed by denaturation at 94 °C for 30 s, annealing at 50 °C for 30 s, extension at 72 °C for 1 min for 35 cycles, followed by supplemental extension at 72 °C for 30 s, and finally cooling at 12 °C for 1 min to be used. PCR products were extracted on a 1.2% agarose gel for electrophoretic analysis and observed in a UV gel imager for the presence or absence of target bands of specific molecular weight size (about 412 bp), and gel images were saved.
+ Open protocol
+ Expand
8

RUNX3 Expression in Endometrial Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
RT-PCR was performed in order to detect the expression of RUNX3 mRNA in the endometrial cancer cell lines, two normal endometrium and cancer tissues. Total RNA was extracted using a QIAamp RNA kit (Qiagen, Inc., Valencia, CA, USA). Reverse transcription was performed using 5 µg total RNA with the Superscript II First-Strand Synthesis system (Thermo Fisher Scientific, Inc.) using oligo(dT) primers. The PCR components were as follows: 0.5 µl forward primer (10 pmol), 0.5 µl reverse primer (10 pmol), 1 µl cDNA, 2 µl 2.5 mM dNTPs, 3 µl of 5XQ buffer, 1 U Taq DNA polymerase (Qiagen, Inc.) and dH2O to reach a final volume of 30 µl. The primer pair for the human RUNX3 forward, 5′-AGACAGCCTGGGCTGGTAAA-3′ and reverse, 5′-TCAGATGAGTGCAGCAGGTG-3′; and GAPDH forward, 5′-CTTAGCACCCCTGGCCAAG-3′ and reverse, 5′-GATGTTCTGGAGAGCCCCG-3′. The PCR conditions were as follows: Initial denaturation for 15 min at 95°C; 35 cycles of denaturation at 95°C for 30 sec, annealing at 63°C for 30 sec and extension at 72°C for 30 sec; and a final extension for 5 min at 72°C. PCR was carried out using a thermal cycler (PTC-200; MJ Research, Inc., Waltham, MA, USA). PCR products were evaluated by electrophoresis on ethidium bromide-stained 2% agarose gels and by digital capillary electrophoresis.
+ Open protocol
+ Expand
9

RNA Extraction and SARS-CoV-2 Detection via RT-PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ribonucleic acid (RNA) was extracted from the collected concentrates using a QIAamp RNA kit (QIAGEN, Valencia, CA, USA) according to the manufacturer's instructions. The RNA extracts were used as templates in the RT-PCR assay for SARS-CoV-2 detection using the VERI-Q nCoV-OM detection kit. Each PCR reaction mix consisted of 10 μl of 2x One-Step RT-PCR Master mix, 1 μl Primer/Probe mixture, 1 μl internal positive control, and 8 μl of the RNA template in a total volume of 20 μl. RNA-positive and RNA-negative (nuclease-free water) controls were included in each PCR run. The PCR was performed in an ABI 7500 RT-PCR system (Life Technologies, Grand Island, NY, USA). The cycling conditions were set at 50°C for 10 minutes in 1 cycle, 95°C for 3 minutes in 1 cycle, 95°C for 9 seconds, and 58°C for 30 seconds in 45 cycles.
+ Open protocol
+ Expand
10

One-step RT-dPCR for SARS-CoV-2 N gene quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
After RNA extraction with the Qiagen QiaAmp RNA kit, one step RT-dPCR reactions were carried out as described in [9 (link)]. For N gene quantification, a duplex assay was performed using China N and SarE genes with primers and probe concentrations of 400 nM and 200 nM, respectively, and optimized by varying the annealing temperature. The sequence of China N and SarE primers is described in [9 (link)–11 (link)], Droplet generation was conducted as described in [9 (link)]. The PCR was performed under the following conditions: 60 min reverse transcription at 50 ºC and 10 min enzyme inactivation at 95 ºC followed by 45 cycles using a two-step thermal profile of 30 s denaturation at 95 ºC and 60 s annealing and extension at 55 ºC; followed by 10 min at 98 ºC and then cooled to 4 ºC. Following thermal cycling, the PCR plates were transferred to a droplet reader (QX200 BioRad, USA) and the data analyzed using QuantaSoft Analysis Pro 1.0.596 (BioRad, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!